BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 7709664)

  • 1. [Preoperative (neoadjuvant) chemotherapy in multimodality treatment concept of stomach carcinoma].
    Meyer HJ; Jähne J; Wilke H; Pichlmayr R
    Zentralbl Chir; 1995; 120(2):128-34. PubMed ID: 7709664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
    Bösing NM; Heise JW; Röher HD
    Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
    Rosen H
    Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is neoadjuvant therapy for locally advanced stomach carcinoma standard?].
    Ajani JA
    Chirurg; 2002 Apr; 73(4):312-5. PubMed ID: 12063914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
    Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
    J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The German EORTC Study of neoadjuvant therapy of stomach carcinoma].
    Siewert JR; Schuhmacher C; Fink U
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():717-9. PubMed ID: 9931709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preoperative downstaging in advanced stomach carcinoma. Wishful thinking or reality].
    Schuhmacher C; Fink U; Siewert JR
    Zentralbl Chir; 2000; 125(4):333-40. PubMed ID: 10829313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status and future perspectives in gastric cancer management.
    Roukos DH
    Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypothetical and reliable aspects of pre-, intra- and postoperative adjuvant therapy of stomach carcinoma].
    Meyer HJ; Opitz GJ; Jähne J; Wilke H
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():312-7. PubMed ID: 9931631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma].
    Ausch C; Rosen HR; Schiessel R
    Wien Klin Wochenschr; 1996; 108(16):496-504. PubMed ID: 8967093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
    Persiani R; Rausei S; Pozzo C; Biondi A; Barone C; Cananzi FC; Schinzari G; D'Ugo D
    Ann Surg Oncol; 2008 Aug; 15(8):2146-52. PubMed ID: 18543037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined modality therapy of gastric cancer.
    Karpeh MS; Kelsen DP
    Surg Oncol Clin N Am; 1997 Oct; 6(4):741-7. PubMed ID: 9309091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical therapy of non-Hodgkin lymphoma of the stomach].
    Zippel K; Agnes A; Zieren HU
    Zentralbl Chir; 1998; 123(1):53-7. PubMed ID: 9542031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New insights in the adjuvant treatment of gastric cancer].
    Jansen EP; Boot H; Cats A; van Coevorden F; Zoetmulder FA; Verheij M
    Ned Tijdschr Geneeskd; 2004 Dec; 148(51):2529-34. PubMed ID: 15636473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.